CRISPR patent splits former colleagues

Emmanuelle Charpentier of the Helmholtz Centre for Infection Research and Jennifer Doudna of the University of California, Berkeley, are pioneers in the field of a genome editing technique known as CRISPR, but the first U.S. patent was awarded to Feng Zhang, Doudna's partner at startup Editas Medicine. Charpentier, who founded CRISPR Therapeutics, says she retains some intellectual property rights. Doudna says the platform allows multiple players.

View Full Article in:

Scientist online, The · Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA